122 related articles for article (PubMed ID: 25709470)
21. Current evidence on the relationship between rs1256049 polymorphism in estrogen receptor-β gene and cancer risk.
Dai ZJ; Wang BF; Ma YF; Kang HF; Diao Y; Zhao Y; Lin S; Lv Y; Wang M; Wang XJ
Int J Clin Exp Med; 2014; 7(12):5031-40. PubMed ID: 25664002
[TBL] [Abstract][Full Text] [Related]
22. Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.
Li X; Qu L; Zhong Y; Zhao Y; Chen H; Daru L
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1433-47. PubMed ID: 23644699
[TBL] [Abstract][Full Text] [Related]
23. Genetic variation of XPA gene and risk of cancer: a systematic review and pooled analysis.
Ding D; Zhang Y; Yu H; Guo Y; Jiang L; He X; Ma W; Zheng W
Int J Cancer; 2012 Jul; 131(2):488-96. PubMed ID: 21866550
[TBL] [Abstract][Full Text] [Related]
24. Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis.
Dong J; Dai J; Zhang M; Hu Z; Shen H
J Gastroenterol Hepatol; 2010 Jun; 25(6):1042-50. PubMed ID: 20594217
[TBL] [Abstract][Full Text] [Related]
25. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.
Tan X; Wang Y; Shi L; Xian L; Guo J; Liang G; Chen M
Genet Test Mol Biomarkers; 2014 Jan; 18(1):50-6. PubMed ID: 24083550
[TBL] [Abstract][Full Text] [Related]
27. XPC Polymorphism Increases Risk of Digestive System Cancers: Current Evidence from A Meta-Analysis.
Jiang X; Zhou LT; Zhang SC; Chen K
Chin J Cancer Res; 2012 Sep; 24(3):181-9. PubMed ID: 23359774
[TBL] [Abstract][Full Text] [Related]
28. The -765G>C polymorphism in the cyclooxygenase-2 gene and digestive system cancer: a meta-analysis.
Zhao F; Cao Y; Zhu H; Huang M; Yi C; Huang Y
Asian Pac J Cancer Prev; 2014; 15(19):8301-10. PubMed ID: 25339021
[TBL] [Abstract][Full Text] [Related]
29. Relationship between Aurora-A V57I Polymorphism and the Risk of Cancer: A Meta-Analysis and Trial Sequential Analysis.
Chen G; Hu C; Song Y; Xiu M; Zhang Y; Lai P; Li Y; Liu X; Huang P
J Cancer; 2020; 11(11):3225-3234. PubMed ID: 32231728
[No Abstract] [Full Text] [Related]
30. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
31. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
32. The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies.
Huang X; Gao Y; He J; Cai J; Ta N; Jiang H; Zhu J; Zheng J
J Cancer; 2016; 7(2):144-52. PubMed ID: 26819637
[TBL] [Abstract][Full Text] [Related]
33.
Wang LN; Wang F; Liu J; Jin YH; Fang C; Ren XQ
Front Physiol; 2017; 8():1081. PubMed ID: 29326607
[No Abstract] [Full Text] [Related]
34. Association between Val66Met polymorphisms in brain-derived neurotrophic factor gene and asthma risk: a meta-analysis.
Xie X; Zhu Y; Zhang J; Zhai C; Feng W; Pan Y; Liu L; Su X; Yang L; Li M
Inflamm Res; 2015 Nov; 64(11):875-83. PubMed ID: 26289094
[TBL] [Abstract][Full Text] [Related]
35. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
36. The correlation analysis of tumor necrosis factor-alpha-308G/A polymorphism and venous thromboembolism risk: A meta-analysis.
Gao Q; Zhang P; Wang W; Ma H; Tong Y; Zhang J; Lu Z
Phlebology; 2016 Oct; 31(9):625-31. PubMed ID: 26405065
[TBL] [Abstract][Full Text] [Related]
37. Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies.
Moazeni-Roodi A; Ghavami S; Hashemi M
Microrna; 2019; 8(2):94-100. PubMed ID: 30514199
[TBL] [Abstract][Full Text] [Related]
38. Association between STAT3 polymorphisms and cancer risk: a meta-analysis.
Yan R; Lin F; Hu C; Tong S
Mol Genet Genomics; 2015 Dec; 290(6):2261-70. PubMed ID: 26063618
[TBL] [Abstract][Full Text] [Related]
39. PLCE1 rs2274223 polymorphism and susceptibility to esophageal cancer: a meta-analysis.
Guo LY; Yang N; Hu D; Zhao X; Feng B; Zhang Y; Zhai M
Asian Pac J Cancer Prev; 2014; 15(21):9107-12. PubMed ID: 25422186
[TBL] [Abstract][Full Text] [Related]
40. Association between the CYP1A2 rs762551 Polymorphism and Bladder Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies.
Zeng Y; Jiang HY; Wei L; Xu WD; Wang YJ; Wang YD; Liu C
Asian Pac J Cancer Prev; 2015; 16(16):7249-54. PubMed ID: 26514519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
